• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    7.36 Up 0.31(4.40%) Mar 4, 4:00PM EST
    Add to Portfolio
    Prev Close:7.05
    Open:7.05
    Bid:7.05 x 1000
    Ask:7.72 x 200
    1y Target Est:21.40
    Beta:3.81
    Earnings Date:Mar 16 - Mar 20 (Est.)
    Day's Range:6.95 - 7.42
    52wk Range:6.33 - 15.56
    Volume:501,611
    Avg Vol (3m):659,192
    Market Cap:445.95M
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INO

    Comparison

    Symbol% ChgMkt Cap
    INOUp 4.40%445.95M
    AZNDown 0.72%85.62B
    PFEUp 0.23%212.30B
    SNYUp 0.54%127.21B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):43.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.61
    Quarterly EPS Est (Dec-14) :-0.10
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback